Posted by Jack Davis on November 12th, 2008 at 12:04 pm | Categorized as Aryx Therapeutics, Biotech, Private placements | Tagged as Aryx Therapeutics, Biotechnology, Private placements
Aryx Therapeutics, the Fremont biopharamaceutical whose shares were slammed last July when Procter & Gamble pulled out of a partnership in developing Aryx’s drug to treat chronic constipation and abdominal pain, said today that it had raised $21.6 million through a private placement of about 9.6 million shares, along with the sale of warrants good on a potential 2.9 million additional shares.
The purchase price for the new shares was pegged at Read the rest of this entry »
Leave a comment
Posted by Jack Davis on September 12th, 2007 at 5:12 pm | Categorized as Green technology, Planktos, Private placements
Planktos, a Foster City company with no sales, 20 employees no employees and less that $15,000 in cash as of June 30, said Wednesday in a press release it secured up to $2 million in a private placement by an investor it didn’t name.
(I’ve been told via e-mail by Planktos Chief Operating Officer William Coleman that in fact the company has “13 employees in Foster City and 7 on the Weatherbird currently berthed in Ft. Lauderdale. — JD 9/17/07)
The investment valued Planktos at $1 a share. A stock chart on the company’s Web site was last updated Aug. 15, when the shares traded at $1.04. The shares, which trade over the counter, closed Wednesday at 54 cents.
Read the rest of this entry »
Leave a comment
Subscribe via RSS all feeds